Dynamic Technology Lab Private LTD Aptevo Therapeutics Inc. Transaction History

Dynamic Technology Lab Private LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.01 - $22.16 $210,470 - $310,727	-14,022 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$27.86 - $40.59 $22,845 - $33,283	820 Added 6.21%	14,022 $428,000
Q4 2020 Feb 11, 2021	BUY	$6.21 - $48.36 $81,984 - $638,448	13,202 New	13,202 $484,000

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $1.58M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.